NANOBIOTIX ANNOUNCES THAT IT HAS SUBMITTED ITS 2021 UNIVERSAL REGISTRATION DOCUMENT WITH THE ANNUAL FINANCIAL REPORT AND ITS 2021 “FORM 20-F”

PARIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Regulatory News: NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the “ Company “), a French biotechnology company in late-stage clinical development, a pioneer in physics-based approaches to expand treatment options for cancer patients, today announces the submission of its Universal Reference Document for the fiscal year ending December 31, 2021 at … Read more